YHLO News
中文版 English
News
News > YHLO News
World Heart Day
      Date:2019-09-29



On this World Heart Day, Cardiovascular disease (CVD) comes to our eyes again. CVD is the leading cause of death and disease burden globally. Studies have shown that 17.9 million people died from CVDs in 2016, and 85% were due to heart attack and stroke.


An early diagnosis of cardiovascular diseases such as Acute Myocardial Infarction (AMI) facilitates rapid decision making and treatment and therefore improves the outcome in patients.

YHLO offers a comprehensive and complete diagnostic solution for the early detection and monitoring of CVDs.

Acute Myocardial Infarction
Troponin – I
CK – MB
Myoglobin
D – Dimer
NT-proBNP
H – FABP

Coronary Artery Diseases
hsCRP
Adiponectin *

Thromboembolic Disease
Anti-cardiolipin antibodies (IgAGM) *
β2 Glycoprotein I IgG/M/A *


* Unique

CopyRight@2019 Shenzhen YHLO Biotech Co., Ltd. rights reserved
Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
Int'l Business Office: Rm.501, Building A1, Kexing Science Park, No.15 Keyuan Road, Nanshan District, 518057 Shenzhen, P.R.China
Tel: +86 755 26601910   /   Fax: +86 755 26473319   /   Email: marketing@szyhlo.com

About YHLONewsProductsServicesJoin UsInvestor RelationsContact Us